• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human BMP-binding endothelial regulator protein (BMPER)

ACP13975

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13975 Target NameBMPER
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range40-685Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8N8U9
Background Information
  • Uniprot Id

    Q8N8U9

  • Target Species

    Human

  • Target Name

    BMPER

  • Target Full Name

    BMP-binding endothelial regulator protein

  • Target Function

    Inhibitor of bone morphogenetic protein (BMP) function, it may regulate BMP responsiveness of osteoblasts and chondrocytes.

  • Target Involvement

    Diaphanospondylodysostosis (DSD)

  • Target Subcellular Location

    Secreted.

  • Target Tissue Specificity

    Highly expressed in lung, and brain and also in primary chondrocytes.

  • Target Synonyms

    BMP binding endothelial regulator; BMP binding endothelial regulator precursor protein; BMP-binding endothelial regulator protein; BMPER; BMPER_HUMAN; Bone morphogenetic protein binding endothelial cell precursor derived regulator; Bone morphogenetic protein-binding endothelial cell precursor-derived regulator; CRIM3; Crossveinless 2; CV 2; CV2; hCV2; Protein crossveinless 2; Protein crossveinless-2

Inquire Recombinant Human BMP-binding endothelial regulator protein (BMPER) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification